Circulating Beta-Hydroxybutyrate Levels in Advanced Heart Failure with Reduced Ejection Fraction: Determinants and Prognostic Impact
European Journal of Heart Failure · 01.09.2024 · 26 (9) · 1931-1940
DOI: 10.1002/ejhf.3324 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 10.06.2024. Verfasst von Luca Monzo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic. Hauptthemen laut MEDLINE: Heart Failure, 3-Hydroxybutyric Acid, Stroke Volume, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Health of the Czech Republic, Institute for Clinical and Experimental Medicine - IKEM, National Institute for Research of Metabolic and Cardiovascular Diseases of the Czech Republic.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Patients with heart failure (HF) display metabolic alterations, including heightened ketogenesis, resulting in increased beta-hydroxybutyrate (β-OHB) formation. We aimed to investigate the determinants and prognostic impact of circulating β-OHB levels in patients with advanced HF and reduced ejection fraction (HFrEF). Methods and results A total of 867 patients with advanced HFrEF (age 57 ± 11 years, 83% male, 45% diabetic, 60% New York Heart Association class III), underwent clinical and echocardiographic examination, circulating metabolite assessment, and right heart catheterization (n = 383). The median β-OHB level was 64 (interquartile range [IQR] 33–161) μmol/L (normal 0–74 μmol/L). β-OHB levels correlated with increased markers of lipolysis (free fatty acids [FFA]), higher natriuretic peptides, worse pulmonary haemodynamics, and lower humoral regulators of ketogenesis (insulin/glucagon ratio). During a median follow-up of 1126 (IQR 410–1781) days, there were 512 composite events, including 324 deaths, 81 left ventricular assist device implantations and 107 urgent cardiac transplantations. In univariable Cox regression, increased β-OHB levels (T3 vs. T1: hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.13–1.72, p = 0.002) and elevated FFA levels (T3 vs. T1: HR 1.39, 95% CI 1.09–1.79, p = 0.008) were both predictors of a worse prognosis. In multivariable Cox analysis evaluating the simultaneous associations of FFA and β-OHB levels with outcomes, only FFA levels remained significantly associated with adverse outcomes.
Conclusions
In patients with advanced HFrEF, increased plasma β-OHB correlate with FFA levels, worse right ventricular function, greater neurohormonal activation and other markers of HF severity. The association between plasma β-OHB and adverse outcomes is eliminated after accounting for FFA levels, suggesting that increased β-OHB is a consequence reflecting heightened lipolytic state, rather than a cause of worsening HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
- Université de Lorraine, Centre d'Investigations Cliniques Plurithématique 1433 and Inserm U1116, CHRU Nancy, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
- Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
ORCID-Profile: Luca Monzo
Förderung
- Ministry of Health of the Czech Republic
- Institute for Clinical and Experimental Medicine - IKEM
- National Institute for Research of Metabolic and Cardiovascular Diseases of the Czech Republic
- European Union - Next Generation EU
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Monzo, L., Kovar, J., Borlaug, B. A., Benes, J., Kotrc, M., Kroupova, K., Jabor, A., Franekova, J., & Melenovsky, V. (2024). Circulating Beta-Hydroxybutyrate Levels in Advanced Heart Failure with Reduced Ejection Fraction: Determinants and Prognostic Impact. European Journal of Heart Failure, 26(9), 1931-1940. https://doi.org/10.1002/ejhf.3324
Vancouver
Monzo L, Kovar J, Borlaug BA, Benes J, Kotrc M, Kroupova K, et al. Circulating Beta-Hydroxybutyrate Levels in Advanced Heart Failure with Reduced Ejection Fraction: Determinants and Prognostic Impact. European Journal of Heart Failure. 2024;26(9):1931-1940. doi:10.1002/ejhf.3324
BibTeX
@article{Monzo2024,
author = {Monzo, Luca and Kovar, Jan and Borlaug, Barry A and Benes, Jan and Kotrc, Martin and Kroupova, Katerina and Jabor, Antonin and Franekova, Janka and Melenovsky, Vojtech},
title = {Circulating Beta-Hydroxybutyrate Levels in Advanced Heart Failure with Reduced Ejection Fraction: Determinants and Prognostic Impact},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {9},
pages = {1931--1940},
doi = {10.1002/ejhf.3324}
}
EUVIMED